These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 636368)

  • 21. [Study of bacterial allergy in acute appendicitis by the method of leukocyte migration inhibition in vitro].
    Shturich PI; Novikov DK; Adamenko GP
    Vestn Khir Im I I Grek; 1976 Apr; 116(4):51-5. PubMed ID: 785785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.
    Zielinski C; Pehamberger H; Endler AT; Knapp W
    Clin Exp Immunol; 1979 Oct; 38(1):92-8. PubMed ID: 393441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indirect leukocyte migration assay in patients with malignant melanoma.
    Morrison LJ; Cochran AJ; Mackie RM; Ross CE; Todd G; Garland C; Garland G
    Int J Cancer; 1979 Jul; 24(1):11-6. PubMed ID: 383631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitization study of oncological patients to bacterial allergens with the aid of the leukocyte migration inhibition reaction].
    Kochetkova VA; Znamenskaia IN
    Vopr Onkol; 1981; 27(2):39-43. PubMed ID: 7210594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-directed immunity in human neuroblastoma.
    Morrison LJ; Cochran AJ; Baird GM; Campbell AM; Willoughby ML
    Am J Pediatr Hematol Oncol; 1982; 4(1):3-9. PubMed ID: 7046494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the immune status of melanoma patients: cell-mediated immune reactions in intracutaneous and epicutaneous tests in the lymphocyte transformation test and the leukocyte-migration inhibition test before and during BCG immunotherapy (author's transl)].
    Knopf B; Wätzig V; Knöll B
    Arch Geschwulstforsch; 1978; 48(8):722-8. PubMed ID: 753194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic profile of malignant melanoma as a basis for further treatment].
    Hausner P; Bauer J; Vosmík F; Votava V; Pastorová J; Kulhánek V; Stanová M
    Cesk Dermatol; 1980 Aug; 55(4):258-63. PubMed ID: 7407963
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cell immunity indices in carcinoma of the gastrointestinal tract].
    Kurtenkov OA
    Vopr Onkol; 1976; 22(10):14-8. PubMed ID: 1014487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Isolation of soluble tumor-associated antigens of human malignant melanoma].
    Suter L
    Fortschr Med; 1978 Aug; 96(32):1615-8. PubMed ID: 680624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on antigenicity and immunogenicity of transplantable melanoma in hamster by using migration inhibition test.
    Kozłowska K; Zurawska-Czupa B; Kostulak A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):445-7. PubMed ID: 749795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
    McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
    J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma.
    Peterson AC; Harlin H; Gajewski TF
    J Clin Oncol; 2003 Jun; 21(12):2342-8. PubMed ID: 12805336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of cellular immunity in rheumatoid arthritis: inhibition of leucocyte migration by a synovial extract.
    Kahan A; Alcalay M; Amor B; Delbarre F
    Biomedicine; 1975 Apr; 23(3):111-5. PubMed ID: 1222225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte migration inhibition by cancer patients' sera.
    Cochran AJ; Mackie RM; Ross CE; Ogg LJ; Jackson AM
    Int J Cancer; 1976 Sep; 18(3):274-81. PubMed ID: 1066319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant reduction of T-cell chemotaxis to MCP-1 in patients with primary and metastatic melanoma.
    Zheng M; Sun G; Cai S; Mueller R; Mrowietz U
    Chin Med J (Engl); 1999 Jun; 112(6):493-6. PubMed ID: 11601324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy].
    Lejeune FJ; Bernheim JL; Vanwijck R
    Acta Chir Belg; 1974 Mar; 73(2):265-93. PubMed ID: 4450923
    [No Abstract]   [Full Text] [Related]  

  • 40. Proceedings: cellular immunity to malignant melanoma.
    Grant RM; Cochran AJ; Thomas CE; Mackie RM; Cameron-Mowat DE; Spilg WG; Norman JN
    Br J Surg; 1973 Nov; 60(11):905. PubMed ID: 4752760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.